Generics Made in India to Storm Japanese Market with Overwhelming Price Advantage

April 10, 2012
Taking advantage of the Economic Partnership Agreement (EPA) between Japan and India that went into effect in August 2011, India’s pharmaceutical industry is engaged in a full-scale marketing offensive in Japan. As part of a government campaign, Indian government officials...read more